How effective is Dovato for Hiv Infection? (a real world drug study)
Summary:
Overall ratings: 4.3/5 Long term ratings: 4.2/5
This is a phase IV clinical study of how effective Dovato (dolutegravir sodium; lamivudine) is for Hiv infection and for what kind of people. The study is created by eHealthMe from 7 Dovato users and is updated continuously.
What is Dovato?
Dovato has active ingredients of dolutegravir sodium; lamivudine. It is often used in hiv infection. eHealthMe is studying from 2,537 Dovato users. Check the latest studies of Dovato.
What is Hiv infection?
Hiv infection is found to be associated with 210 drugs and 532 conditions by eHealthMe. Check the latest studies of Hiv infection.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
7 people are studied for taking Dovato in Hiv infection
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Dovato effectiveness for Hiv infection (number of people):
Overall:
- not at all: 0
- somewhat: 0
- moderate: 0
- high: 5
- very high: 2
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 0
- high: 5
- very high: 1
Gender of people who take Dovato for Hiv infection *:
- female: 14.29 %
- male: 85.71 %
Age of people who take Dovato for Hiv infection *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 14.29 %
- 40-49: 14.29 %
- 50-59: 57.14 %
- 60+: 14.29 %
Who find Dovato more effective for Hiv Infection?
Gender of people who take Dovato for Hiv infection *:
- female: 14.29 %
- male: 85.71 %
Age of people who take Dovato for Hiv infection *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 14.29 %
- 40-49: 14.29 %
- 50-59: 57.14 %
- 60+: 14.29 %
* Approximation only. Some reports may have incomplete information.
Do you take Dovato?
- You can start a phase IV clinical trial to monitor Dovato safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Dovato (2,537 reports)
Treatments, associated drugs and conditions:
- Hiv infection (176,056 reports)
How the study uses the data?
The study is based on dolutegravir sodium; lamivudine (the active ingredients of Dovato) and Dovato (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Soft Tissue Infection and drugs of ingredients of estradiol - 4 seconds ago
- Could Ciprofloxacin cause Cardiac Arrest? - 4 seconds ago
- Azelastine Hydrochloride and Sinusitis - Acute for Women aged 30-39 - 6 seconds ago
- Azelastine Hydrochloride and Sinus Infection for Women aged 30-39 - 6 seconds ago
- Azelastine Hydrochloride and Acute Sinusitis for Women aged 30-39 - 6 seconds ago
- Azelastine Hydrochloride and Sinusitis for Women aged 30-39 - 7 seconds ago
- Could Aspirin cause Application Site Erythema? - 9 seconds ago
- Atarax and Dyspnoea for Men aged 60+ - 11 seconds ago
- Atarax and Dyspnea for Men aged 60+ - 11 seconds ago
- Drug interactions of Plendil and Vioxx - 12 seconds ago